Regeneron Pharmaceuticals, Inc. (REGN) Dividend Yield, History & Forecast

Regeneron Pharmaceuticals, Inc. (REGN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. It pays a current dividend yield of 0.47% ($3.70 per share annually (TTM)). The most recent ex-dividend date was August 18, 2026, with payment scheduled for August 31, 2026. The trailing twelve-month payout ratio is 8.7%; the market capitalization is approximately $80.51B. Review REGN dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

Loading quote...

Frequently Asked Questions about Regeneron Pharmaceuticals, Inc. (REGN)

What is Regeneron Pharmaceuticals, Inc.'s dividend yield?
Regeneron Pharmaceuticals, Inc. (REGN) pays a current trailing twelve-month dividend yield of 0.47%, which works out to $3.70 per share annually based on the most recent payout schedule.
When does Regeneron Pharmaceuticals, Inc. pay its next dividend?
The most recent ex-dividend date was August 18, 2026. The next scheduled dividend payment date is August 31, 2026.
Is Regeneron Pharmaceuticals, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Regeneron Pharmaceuticals, Inc. in?
Regeneron Pharmaceuticals, Inc. (REGN) operates in the Healthcare sector, specifically the Biotechnology industry.
What is Regeneron Pharmaceuticals, Inc.'s dividend payout ratio?
Regeneron Pharmaceuticals, Inc. (REGN)'s trailing twelve-month dividend payout ratio is 8.7%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.